Dutch suturing tech company Mellon Medical said today that it has raised €6 million (equivalent to about $6.6 million) to advance its Switch instrument.
Mellon Medical officials boast that their Switch single use precision-suturing instrument enables surgeons to suture tubular and layered structures about twice as fast as conventional methods. Reduced clamp time for many cardiovascular procedures equals reduced complications risk, better patient outcomes and reduced costs, according to the company.